— Know what they know.
Not Investment Advice

ACLX NASDAQ

Arcellx, Inc.
1W: +0.0% 1M: +0.2% 3M: +68.6% YTD: +81.7% 1Y: +77.8% 3Y: +180.7%
$115.07
Last traded 2026-05-15 — delisted
NASDAQ · Healthcare · Biotechnology · $6.7B mcap · 43M float · 3.37% daily turnover · Short 30% of daily vol

📊 Key Metrics

TTM
$22M
Revenue
-79.4% YoY
$-229M
Net Income
-113.3% YoY
$-213M
Free Cash Flow
-119.4% YoY
0.8%
Gross Margin
-3850.2%
Op. Margin
-3513.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-53.4%
ROA-34.8%
ROIC-414.2%

Valuation

P/E-39.1
P/B16.1
EV/EBITDA-16.8

Leverage

Debt/Equity0.24
Current Ratio4.44
Interest Cov.-8.5x

Quality Scores

Piotroski F1/9
Altman Z8.87
Beneish M62.58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms